Psilocybin for Methamphetamine Addiction — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Psilocybin for Methamphetamine Addiction — Stella

Home/Methamphetamine Use Disorder/

View on ClinicalTrials.gov

Recruiting

Back to Methamphetamine Use Disorder trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

LSU Health Shreveport, Shreveport, Louisiana

Key details

Phase

Very early testing

Sponsor

Kevin Murnane

Enrollment target

~20 participants

Started

April 2025

Primary completion

March 2027

Age range

25 Years – 65 Years

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.